GGrantIndex
← Leaderboards

Analytical Diagnostic Solutions, Inc.

Mount Laurel, NJ

Compare ↔
$9,026,709
Total funding
11
Grants

Funding over time

peak $2M · FY201725
$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,026,709 · 11

By mechanism

R44$4,300,289 · 3
SB1$2,893,164 · 1
R43$1,833,256 · 7

Investigators at Analytical Diagnostic Solutions, Inc.

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

All-Time

Most funded here, all years

Largest grants

A point-of-care device for phenylalanine determination$1,002,084
R44 · FY2021 · GM
PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)$990,200
SB1 · FY2021 · AI
PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)$982,381
SB1 · FY2023 · AI
A point-of-care device for phenylalanine determination$944,873
R44 · FY2020 · GM
PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)$920,583
SB1 · FY2022 · AI
A point of care-device for the determination of creatinine phosphokinase (CPK), theCPK Now$906,002
R44 · FY2025 · HD
A user-friendly point-of-care device for G6PDH determination$873,090
R44 · FY2019 · AI
A user-friendly point-of-care device for G6PDH determination$574,240
R44 · FY2020 · AI
A point-of-care device for the determination of homocysteine (Hcy), the Hcy Now$305,352
R43 · FY2025 · TR
ADA2 Diagnostic Platform: Point-of-care test for determination of patient enzyme levels for diagnosis of the rare disease Deaminase2 Deficiency (DADA2)$300,000
R43 · FY2023 · AI
A point of care-device for the determination of creatinine phosphokinase (CPK), the CPK Now$295,923
R43 · FY2023 · HD
PKU Now-Connect: An intelligent digital ecosystem to improve health outcomes in Phenylketonuria$291,361
R43 · FY2023 · NS
A point-of-care device for the determination of the Bilirubin, the BiliNow$224,700
R43 · FY2018 · HD
A point-of-care device for phenylalanine determination$224,700
R43 · FY2018 · GM
A user-friendly point-of-care device for G6PDH determination$191,220
R43 · FY2017 · AI